Latest Research

T Wang et al, 2020. Association between coffee consumption and functional disability in the U.S older adults, British Journal of Nutrition, published online.

C T Hong et al, 2020. The effect of caffeine on the risk and progression of Parkinson's disease: a meta-analysis, Nutrients, Volume 12.

G Schepici et al, 2020. Caffeine: An overview of its beneficial effects in experimental models and clinical trials of Parkinson's disease, International Journal of Molecular Science, Volume 21 (13).

C H Tong et al, 2020. The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis, Nutrients, Volume 12 (6)

J W Kim et al, 2019. Coffee intake and decreased amyloid pathology in human brain, Translational Psychiatry, Volume 9 (1).

C Boulos et al, 2019. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence, Nutrients, Volume 11 (8).

M A Kromhout et al, 2019. Caffeine and neuropsychiatric symptoms in patients with dementia: a systematic review, Experimental Gerontology, published online.

S C Larsson and N Orsini, 2018. Coffee Consumption and Risk of Dementia and Alzheimer's Disease: A Dose-response Meta-Analysis of Prospective Studies, Nutrients, Volume 10 (10).

A Hussain et al, 2018. Caffeine: a potential protective agent against cognitive decline in Alzheimer’s disease, Critical Review in Eukaryiotic Gene Expression, Volume 28 (1).

B H Cho et al, 2018. Association of Coffee Drinking and Non-motor Symptoms in Drug Naive, Early Stage Parkinson's Disease, Parkinsonism and Related Disorders, published online.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.